台股 » 個股 » 醣聯 » 籌碼相關 » 券商分點績效

醣聯

(4168)
可現股當沖
  • 股價
    25.30
  • 漲跌
    --
  • 漲幅
    0.00%
  • 成交量
    150
  • 產業
    上櫃 生技醫療類股
  • 101人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
醣聯 (4168)籌碼相關-券商分點績效/獲利分析
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

«前一日     2024/04/18 ~ 2024/05/02     後一日»

券商獲利排行 - 2024/04/18 ~ 2024/05/02

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  1.58%14.7014.7-3603625.7025.725.3
  2.18%12.4012.4-2202225.9025.925.3
  2.34%12.1012.1-2002025.9025.925.3
  0.37%11.73.18.5-329012225.625.525.625.3
  2.05%10.6010.6-2002025.8025.825.3
  2.27%10010-1701725.9025.925.3
  1.59%909-2202225.7025.725.3
  1.93%7.507.5-1501525.8025.825.3
  1.36%707-2002025.7025.725.3
  2.00%6.706.7-1301325.8025.825.3
  0.74%5.705.7-3003025.5025.525.3
  1.53%5.105.1-1301325.7025.725.3
  1.94%50.54.5-911025.825.325.825.3
  0.66%4.60.44.2-11162725.725.725.725.3
  1.40%4.34.5-0.22121025.625.425.825.3
  3.80%404-40426.3026.325.3
  1.90%3.90.43.5-61825.825.425.825.3
  2.88%3.803.8-50526.1026.125.3
  2.05%3.70.53.2-61725.825.325.825.3
  1.42%3.703.7-1001025.7025.725.3
  2.69%3.503.5-5052602625.3
  0.96%3.43.9-0.42141125.625.425.825.3
  1.33%3.403.4-1001025.6025.625.3
  1.27%3.303.3-1001025.6025.625.3
  1.17%303-1001025.6025.625.3
  1.39%2.83-0.118725.625.425.925.3
  0.61%2.8-0.63.4-1531825.625.725.525.3
  2.13%2.802.8-50525.9025.925.3
  1.29%2.702.7-80825.6025.625.3
  2.01%2.602.6-50525.8025.825.3
  0.83%2.60.22.4-1111225.525.425.525.3
  1.36%2.502.5-70725.7025.725.3
  3.13%2.502.5-30326.1026.125.3
  1.34%2.40.51.9-42725.625.425.725.3
  2.32%2.402.4-40425.9025.925.3
  2.32%2.402.4-40425.9025.925.3
  2.98%2.302.3-30326.1026.125.3
  1.05%2.20.51.7-62825.525.425.625.3
  0.68%2.12.6-0.5412825.625.425.825.3
  0.82%2.11.60.5-191025.725.725.825.3
  1.01%2.10.41.7-71825.525.225.525.3
  0.78%202-901025.525.825.525.3
  0.96%1.92038525.525.325.725.3
  1.84%1.901.9-40425.8025.825.3
  1.76%1.81.8014325.625.325.925.3
  0.98%1.801.8-60725.627.525.625.3
  1.66%1.71.7004425.525.325.825.3
  0.22%1.7-0.72.4-2283025.425.525.425.3
  0.90%1.601.6-70725.5025.525.3
  0.45%1.501.5-1031325.425.425.425.3

券商虧損排行 - 2024/04/18 ~ 2024/05/02

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  -0.82%-18.5-1-17.573881525.525.525.525.3
  -2.35%-18.20-18.22930025.925.925.825.3
  -2.08%-17.20-17.23232025.825.8025.3
  -1.87%-14.50-14.53030025.825.8025.3
  -0.49%-10.42.5-12.951833225.625.625.625.3
  -0.96%-9.4-0.3-93538325.625.625.525.3
  -0.39%-8.8-11.32.6-8798825.725.725.625.3
  -0.72%-6.9-1.3-5.618371925.625.625.525.3
  -1.30%-6.70.4-7.11820225.725.725.925.3
  -1.74%-6.2-1.9-4.31014425.625.725.325.3
  -1.84%-6.20.2-6.41113225.925.92625.3
  -0.70%-6.1-0.5-5.63134325.525.525.325.3
  -0.90%-6-1.4-4.611261425.725.725.625.3
  -1.56%-6-6.60.6-5101525.726.125.425.3
  -1.20%-60-6-200202502525.3
  -2.52%-5.2-5.2008825.826.125.425.3
  -2.59%-4.70-4.77702626025.3
  -1.75%-4.5-1.5-3610425.725.825.425.3
  -0.98%-4.2-2.4-1.85171125.525.625.425.3
  -1.48%-3.80-3.81010025.725.7025.3
  -1.44%-3.7-2.4-1.3310725.625.725.425.3
  -1.75%-3.60-3.688025.825.8025.3
  -0.90%-3.4-3.40-1141525.425.525.325.3
  -0.66%-3.20.1-3.31419525.525.525.625.3
  -0.78%-3-2.7-0.3-771525.425.725.325.3
  -0.96%-3-2.5-0.40121125.625.725.525.3
  -1.99%-2.6-0.8-1.825225.825.925.525.3
  -0.98%-2.50-2.51010025.625.6025.3
  -1.34%-2.40-2.477025.625.6025.3
  -1.23%-2.20-2.267025.625.625.425.3
  -1.37%-2.1-1.3-0.826425.625.725.425.3
  -0.54%-2.10-2.11515025.425.4025.3
  -0.78%-20-21010025.525.5025.3
  -1.56%-20-245025.725.725.525.3
  -0.28%-1.91-312271525.625.525.625.3
  -1.44%-1.90-1.955025.725.7025.3
  -0.49%-1.80-1.81515025.425.4025.3
  -0.60%-1.80-1.8-1201225.2025.225.3
  -3.39%-1.80-1.822026.226.2025.3
  -2.19%-1.70-1.733025.925.9025.3
  -3.25%-1.70-1.722026.226.2025.3
  -2.06%-1.60-1.633025.825.8025.3
  -3.10%-1.6-0.8-0.812125.826.125.325.3
  -0.24%-1.50-1.52525025.425.4025.3
  -1.17%-1.50-1.545025.625.625.925.3
  -1.46%-1.50-1.544025.725.7025.3
  -0.96%-1.5-1.5006626.126.225.925.3
  -1.96%-1.5-1-0.513225.625.825.325.3
  -0.63%-1.50-1.599025.525.5025.3
  -1.87%-1.50-1.533025.825.8025.3
醣聯攜日商開發骨質疏鬆相似藥 一期臨床納入首位受試者Anue鉅亨-2023/05/23
醣聯 相關文章
醣聯 相關影音